I was prescribed Ritalin when i was 6 years old, and was considered one of the short kid my entire childhood (and suffered the consequences).
I decided to stop taking meds when I was 17, and in a few years became the tallest of my friend group.
I'm older now, and occasionally have periods where I take what I consider "better" meds like Vyvanse, but there ain't no way i'm letting my kids take ANYTHING until they are much much older and can decide for themselves.
The fact that the height of adult males with ADHD is greater than that of males without ADHD (first figure/graphs, G & H) should indicate that there is no causative link that the medication has an impact. For females, the average does not show this, but if you look carefully, the variation is bigger. The same selection bias is possible in this case.
Instead, to me it looks like there is selection bias going on. Shorter males are more likely to get MPH prescribed is an equally valid explanation.
Luckily, the conclusion makes no assertions about height either, nor does the paper make conclusions about any causative relation.
This is not known enough.
I was prescribed Ritalin when i was 6 years old, and was considered one of the short kid my entire childhood (and suffered the consequences).
I decided to stop taking meds when I was 17, and in a few years became the tallest of my friend group.
I'm older now, and occasionally have periods where I take what I consider "better" meds like Vyvanse, but there ain't no way i'm letting my kids take ANYTHING until they are much much older and can decide for themselves.
Anecdotical...Also: "clinically modest, reduction in adult height"
The BMI being higher is slightly interesting (you would guess it would be the reverse), but the height differential seems vanishingly small.
Concerns that stimulant meds taken as children reduced adult height have been around for three decades.
To my mind, the bigger take away here is that ADHD meds don't significantly impact adult height.
The fact that the height of adult males with ADHD is greater than that of males without ADHD (first figure/graphs, G & H) should indicate that there is no causative link that the medication has an impact. For females, the average does not show this, but if you look carefully, the variation is bigger. The same selection bias is possible in this case.
Instead, to me it looks like there is selection bias going on. Shorter males are more likely to get MPH prescribed is an equally valid explanation.
Luckily, the conclusion makes no assertions about height either, nor does the paper make conclusions about any causative relation.
Maybe they have a higher BMI because they become less active :D
Patients with ADHD, particularly those treated with MPH, had a higher BMI and shorter height at adulthood than individuals without ADHD.